triazolam has been researched along with Hypercapnia in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients without severe waking hypoxemia and without carbon dioxide retention, triazolam did not increase either nocturnal hypoxemia or respiratory events during sleep." | 2.66 | Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease. ( Dawson, A; Hajdukovic, RM; Mitler, MM; Timms, RM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Timms, RM | 1 |
| Dawson, A | 1 |
| Hajdukovic, RM | 1 |
| Mitler, MM | 1 |
1 trial available for triazolam and Hypercapnia
| Article | Year |
|---|---|
Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease.
Topics: Aged; Double-Blind Method; Female; Humans; Hypercapnia; Hypoxia; Lung Diseases, Obstructive; Male; M | 1988 |